More widespread use of mammograms, along with the implementation of targeted hormone therapies more than 40 years ago, has ...
Research by UMass Chan Medical School scientists Sharon Cantor, Ph.D., and Jenna M. Whalen, Ph.D., poses a new explanation ...
Oncology, titled "Tumor Metastasis: Mechanistic Insights and Therapeutic Intervention," a research team from Guangzhou ...
where it is taken up by tumor cells that then express tumor suppressor proteins that were deficient in the tumor. The Company's lead product candidate, Reqorsa® Gene Therapy (quaratusugene ozeplasmid) ...
AUSTIN, Texas, Feb. 18, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...
The data, published in eLife, showcase the potential of NPRL2 as a single-agent therapy using the Oncoprex Delivery System. The Oncoprex system delivered the NPRL2 tumor suppressor gene via lipid ...
News Medical on MSN2d
Study unravels the complex interplay of the UPS in cancer development and treatmentA new review published in Genes & Diseases explores the pivotal role of the ubiquitin-proteasome system (UPS) in regulating the tumor microenvironment (TME) and driving cancer progression. The study ...
Genprex’s (GNPX) research collaborators at a major cancer research center in Houston, Texas have published a new study which used the company’s ...
Research reveals promising advancements of Ce6-GFFY in colorectal cancer treatment. Colorectal cancer (CRC) is a highly malignant disease that readily metastasizes to vital organs. Many strategies ...
Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback